ALKS
USDAlkermes plc Ordinary Shares
السعر في الوقت الحقيقي
مخطط الأسعار
المقاييس الرئيسية
مقاييس السوق
الافتتاح
$30.000
الأعلى
$30.630
الأدنى
$29.770
الحجم
0.42M
أساسيات الشركة
القيمة السوقية
5.0B
الصناعة
Drug Manufacturers - Specialty & Generic
البلد
Ireland
إحصاءات التداول
متوسط الحجم
2.00M
البورصة
NMS
العملة
USD
نطاق 52 أسبوعاً
أخبار ذات صلة
Wells Fargo Maintains Overweight on Alkermes, Lowers Price Target to $42
Wells Fargo analyst Benjamin Burnett maintains Alkermes with a Overweight and lowers the price target from $44 to $42.
Needham Maintains Buy on Alkermes, Raises Price Target to $44
Needham analyst Ami Fadia maintains Alkermes with a Buy and raises the price target from $43 to $44.
Alkermes plc Reports Third Quarter 2025 Financial Results
Alkermes plc (Nasdaq: ALKS) today reported financial results for the third quarter of 2025. "Alkermes delivered another successful quarter, achieving ...
Mizuho Maintains Outperform on Alkermes, Raises Price Target to $45
Mizuho analyst Uy Ear maintains Alkermes with a Outperform and raises the price target from $40 to $45.
Piper Sandler Reiterates Overweight on Alkermes, Raises Price Target to $45
Piper Sandler analyst David Amsellem reiterates Alkermes with a Overweight and raises the price target from $38 to $45.
RBC Capital Maintains Outperform on Alkermes, Raises Price Target to $47
RBC Capital analyst Leonid Timashev maintains Alkermes with a Outperform and raises the price target from $45 to $47.
أسهم ذات صلة
NRBO
NeuroBo Pharmaceuticals Inc.
EDAP
EDAP TMS S.A. American Depositary Shares
NGNE
Neurogene Inc.
BJDX
Bluejay Diagnostics Inc.
SMX
SMX (Security Matters) Public Limited Company Ordinary Shares
ابق على اطلاع
تعيين تنبيهات الأسعار، الحصول على تحديثات تحليل الذكاء الاصطناعي وأخبار السوق في الوقت الحقيقي.